Agrawal, A., & Lynskey, M. T. (2014). Cannabis controversies: How genetics can inform the study of comorbidity. Addiction, 109(3), 360–370. https://doi.org/10.1111/add.12436

Article  PubMed  PubMed Central  Google Scholar 

Amado, B. G., Villanueva, V. J., Vidal-Infer, A., & Isorna, M. (2020). Gender differences among cannabis self-cultivators in Spain. Adicciones, 32(3), 181–192. https://doi.org/10.20882/adicciones.1142

Article  CAS  Google Scholar 

American Psychiatric Association. (2002). Manual diagnóstico y estadístico de los trastornos mentales (DSM-IV-TR). Masson.

Arnold, S. R., Uljarević, M., Hwang, Y. I., Richdale, A. L., Trollor, J. N., & Lawson, L. P. (2020). Brief report: Psychometric properties of the patient health Questionaire-9 (PHQ-9) in autistic adults. Journal of Autism and Developmental Disorders, 50, 2217–2225. https://doi.org/10.1007/s10803-019-03947-9

Article  PubMed  Google Scholar 

Baader, T., Molina, J. L., Venezian, S., Rojas, C., Farías, R., Fierro-Freixenet, C., Backenstrass, M., & Mundt, C. (2012). Validity and utility of PHQ9 (Patient Helth Questionnaire) in the diagnosis of depression in user patients of primary care in Chile. Revista Chilena De Neuropsiquiatría, 50(1), 10–22. https://doi.org/10.4067/S0717-92272012000100002

Article  Google Scholar 

Baron, R. M., & Kenny, D. A. (1986). The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51(6), 1173–1182.

Article  CAS  PubMed  Google Scholar 

Becker, J. B., & Chartoff, E. (2018). Sex differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacology, 44(1), 166–183. https://doi.org/10.1038/s41386-018-0125-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Becker, J. B., McClellan, M. L., & Reed, B. G. (2017). Sex differences, gender and addiction. Journal of Neuroscience Research, 95(1–2), 136–147. https://doi.org/10.1002/jnr.23963.

Bélanger, E., Thomas, K. S., Jones, R. N., Epstein-Lubow, G., & Mor, V. (2019). Measurement validity of the Patient-Health Questionnaire-9 in US nursing home residents. International Journal of Geriatric Psychiatry, 34(5), 700–708. https://doi.org/10.1002/gps.5074

Article  PubMed  PubMed Central  Google Scholar 

Bolanis, D., Orri, M., Castellanos-Ryan, N., Renaud, J., Montreuil, T., Boivin, M., ... , Geoffroy, M. C. (2020). Cannabis use, depression and suicidal ideation in adolescence: Direction of associations in a population based cohort. Journal of Affective Disorders, 274, 1076–1083. https://doi.org/10.1016/j.jad.2020.05.136

Boothroyd, L., Dagnan, D., & Muncer, S. (2019). PHQ-9: One factor or two? Psychiatry Research, 271, 532–534. https://doi.org/10.1016/j.psychres.2018.12.048

Article  PubMed  Google Scholar 

Brahim, S., Henia, M., Mohamed, A. H., Chabbouh, M., & Zarrouk, L. (2022). Anxiety and depression disorder among young cannabis users in Tunisia. European Psychiatry, 65(S1), S829–S829. https://doi.org/10.1192/j.eurpsy.2022.2147

Article  PubMed Central  Google Scholar 

Bright, U., & Akirav, I. (2022). Modulation of endocannabinoid system components in depression: Pre-clinical and clinical evidence. International Journal of Molecular Sciences, 23(10), 5526. https://doi.org/10.3390/ijms23105526

Article  CAS  PubMed  PubMed Central  Google Scholar 

Budney, A. J., & Borodovsky, J. T. (2017). The potential impact of cannabis legalization on the development of cannabis use disorders. Preventive Medicine, 104, 31–36. https://doi.org/10.1016/j.ypmed.2017.06.034

Article  PubMed  PubMed Central  Google Scholar 

Bujarski, S. J., Norberg, M. M., & Copeland, J. (2012). The association between distress tolerance and cannabis use-related problems: The mediating and moderating roles of coping motives and gender. Addictive Behaviors, 37(10), 1181–1184. https://doi.org/10.1016/j.addbeh.2012.05.014

Article  PubMed  Google Scholar 

Cao, H., Zhang, R., Li, L., & Yang, L. (2022). Coping style and resilience mediate the effect of childhood maltreatment on mental health symptomology. Children, 9(8), 1118. https://doi.org/10.3390/children9081118

Article  PubMed  PubMed Central  Google Scholar 

Carrà, G., Bartoli, F., & Crocamo, C. (2019). Trends of major depressive episode among people with cannabis use: Findings from the national survey on drug use and health 2006-2015. Substance Abuse, 40(2), 178–184. https://doi.org/10.1080/08897077.2018.1550464

Article  PubMed  Google Scholar 

Casajuana, C., López-Pelayo, H., Oliveras, C., Colom, J., Gual, A., & Balcells-Oliveró, M. M. (2021). Relación entre las motivaciones para consumir y el consumo problemático de cannabis. Adicciones, 33(1), 31–42. https://doi.org/10.20882/adicciones.1221

Article  Google Scholar 

Cash, M. C., Cunnane, K., Fan, C., & Romero-Sandoval, E. A. (2020). Mapping cannabis potency in medical and recreational programs in the United States. PLoS ONE, 15(3), e0230167. https://doi.org/10.1371/journal.pone.0230167

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cassiani-Miranda, C. A., Pérez-Aníbal, E., Vargas-Hernández, M. C., Herazo-Bustos, M., & Cabarcas-Tovar, A. (2018). Validez de apariencia y adaptación de la escala PHQ-9 para la detección de sintomatología depresiva en universitarios de ciencias de la salud de Cartagena (Colombia). Salud Uninorte, 34(1), 84–96. https://doi.org/10.14482/sun.34.1.9154

Article  Google Scholar 

Cassiani-Miranda, C. A., Cuadros-Cruz, A. K., Torres-Pinzón, H., Scoppetta, O., Pinzón-Tarrazona, J. H., López-Fuentes, W. Y., ... , Llanes-Amaya, E. R. (2021). Validez del Cuestionario de salud del paciente-9 (PHQ-9) para cribado de depresión en adultos usuarios de Atención Primaria en Bucaramanga, Colombia. Revista Colombiana de Psiquiatría, 50(1), 11–21. https://doi.org/10.1016/j.rcp.2019.09.001

Chandra, S., Radwan, M. M., Majumdar, C. G., Church, J. C., Freeman, T. P., & ElSohly, M. A. (2019). New trends in cannabis potency in USA and Europe during the last decade (2008–2017). European Archives of Psychiatry and Clinical Neuroscience, 269(1), 5–15. https://doi.org/10.1007/s00406-019-00983-5

Article  PubMed  Google Scholar 

Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021). Cannabis use and cannabis use disorder. Nature Reviews Disease Primers, 7(1), 16. https://doi.org/10.1038/s41572-021-00247-4

Article  PubMed  PubMed Central  Google Scholar 

Costa, J., Simons, J., Pardo, M., Lleras, M., Pérez, A., & Andión, O. (2018). Spanish version validation of the marihuana motives measure in a drug-consuming adolescent sample. Adicciones, 30, 282–291. https://doi.org/10.20882/adicciones.947

Article  Google Scholar 

Crane, N. A., Langenecker, S. A., & Mermelstein, R. J. (2015). Gender differences in the associations among marijuana use, cigarette use, and symptoms of depression during adolescence and young adulthood. Addictive behaviors, 49, 33–39.

Cuenca-Royo, A. M., Sanchez-Niubo, A., Forero, C. G., Torrens, M., Suelves, J. M., & Domingo-Salvany, A. (2012). Psychometric properties of the CAST and SDS scales in young adult cannabis users. Addictive Behaviors, 37, 709–715. https://doi.org/10.1016/j.addbeh.2012.02.012

Article  PubMed  Google Scholar 

Degenhardt, L., Hall, W., & Lynskey, M. (2003). Exploring the association between cannabis use and depression. Addiction, 98(11), 1493–1504. https://doi.org/10.1046/j.1360-0443.2003.00437.x

Article  PubMed  Google Scholar 

Degenhardt, L., Coffey, C., Romaniuk, H., Swift, W., Carlin, J. B., Hall, W. D., & Patton, G. C. (2013). The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction, 108(1), 124–133. https://doi.org/10.1111/j.1360-0443.2012.04015.x

Article  PubMed  Google Scholar 

Dellazizzo, L., Potvin, S., Beaudoin, M., Luigi, M., Dou, B. Y., Giguère, C. É., & Dumais, A. (2019). Cannabis use and violence in patients with severe mental illnesses: A meta-analytical investigation. Psychiatry Research, 274, 42–48. https://doi.org/10.1016/j.psychres.2019.02.010

Article  PubMed  Google Scholar 

Dierker, L., Selya, A., Lanza, S., Li, R., & Rose, J. (2018). Depression and marijuana use disorder symptoms among current marijuana users. Addictive Behaviors, 76, 161–168. https://doi.org/10.1016/j.addbeh.2017.08.013

Article  PubMed  Google Scholar 

Doi, S., Ito, M., Takebayashi, Y., Muramatsu, K., & Horikoshi, M. (2018). Factorial validity and invariance of the Patient Health Questionnaire (PHQ)-9 among clinical and non-clinical populations. PloS One, 13(7), e0199235. https://doi.org/10.1371/journal.pone.0199235

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eid, R. S., Gobinath, A. R., & Galea, L. A. (2019). Sex differences in depression: Insights from clinical and preclinical studies. Progress in Neurobiology, 176, 86–102. https://doi.org/10.1016/j.pneurobio.2019.01.006

Article  PubMed  Google Scholar 

Esmaeelzadeh, S., Moraros, J., Thorpe, L., & Bird, Y. (2018). Examining the association and directionality between mental health disorders and substance use among adolescents and young adults in the US and Canada -A systematic review and meta-analysis. Journal of Clinical Medicine, 7(12), 543. https://doi.org/10.3390/jcm7120543

Article  PubMed  PubMed Central  Google Scholar 

European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]. (2018). Uso médico del cannabis y los cannabinoides: Preguntas y respuestas para la elaboración de políticas. Publications Office of the European Union. https://www.emcdda.europa.eu/system/files/publications/10171/20185584_TD0618186ESN_PDF.pdf

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA]. (2021). European drug report 2021: Trends and developments. Publications Office of the European Union. https://www.emcdda.europa.eu/system/files/publications/13838/TDAT21001ENN.pdf

European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]. (2022). European drug report 2022: Trends and developments. Publications Office of the European Union. https://www.emcdda.europa.eu/system/files/publications/14644/TDAT22001ENN.pdf

Farinha-Ferreira, M., Rei, N., Fonseca-Gomes, J., Miranda-Lourenço, C., Serrão, P., Vaz, S. H., ... , Sebastião, A. M. (2022). Unexpected short-and long-term effects of chronic adolescent HU-210 exposure on emotional behavior. Neuropharmacology, 214, 109155. https://doi.org/10.1016/j.neuropharm.2022.109155

Feingold, D., & Weinstein, A. (2021). Cannabis and depression. In: Murillo-Rodriguez, E., Pandi-Perumal, S.R., Monti, J.M. (eds) Cannabinoids and neuropsychiatric disorders. Advances in Experimental Medicine and Biology, vol 1264. Springer, Cham. https://doi.org/10.1007/978-3-030-57369-0_5

Finset, A., Steine, S., Haugli, L., Steen, E., & Laerum, E. (2002). The brief approach/avoidance coping questionnaire: Development and validation. Psychology, Health & Medicine, 7(1), 75–85. https://doi.org/10.1080/13548500120101577

Article  Google Scholar 

Folkman, S., & Lazarus, R. S. (1980). An analysis of coping in a middle-aged community sample. Journal of Health and Social Behavior, 21(3), 219–239. https://www.jstor.org/stable/2136617.

Folkman, S., & Lazarus, R. S. (1988). Coping as a mediator of emotion. Journal of Personality and Social Psychology, 54(3), 466–475. https://doi.org/10.1037/0022-3514.54.3.466

Article  CAS  PubMed  Google Scholar 

Franklin, J. M., & Carrasco, G. A. (2013). Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT2A) receptor activity via ERK1/2 signaling. Synapse, 67(3), 145–159. https://doi.org/10.1002/syn.21626

Article  CAS  PubMed